Traditional Chinese Medicine Decoctions Improve Longevity Following Diagnosis with Stage IV Esophageal Squamous Cell Carcinoma: A Retrospective Analysis
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of General Medicine
- Vol. ume 15, 1665-1675
- https://doi.org/10.2147/ijgm.s346536
Abstract
Objective: Traditional Chinese medicine (TCM) is an ancient form of personalized medicine and may improve morbidity and mortality in patients with esophageal cancer. This retrospective study aimed to evaluate the utility of TCM in the treatment of stage IV esophageal squamous cell carcinoma (SCC). Methods: We collected the medical records of patients with stage IV SCC admitted to Henan Provincial Hospital of Traditional Chinese Medicine and Linzhou Hospital of Traditional Chinese Medicine between July 2017 and June 2020. We used univariate and multivariate analyses to determine if the use of TCM improved patient prognosis. Moreover, cluster analysis was used to classify the patients according to TCM syndrome type and identify the most frequently used combinations of remedies. Results: After that 402 patients were included in PSM, of which 196 (48.8%) were treated with traditional Chinese medicine. TCM prolonged the survival time of patients with stage IV esophageal SCC (P=0.084), and was an independently associated with prognosis as demonstrated by Cox multivariate regression analysis [risk ratio (RR) =0.543, 95% confidence interval (CI): 0.390– 0.755, P< 0.001]. Association analysis revealed 75 cases (38.26%) had obstruction of phlegm and qi syndrome, 53 cases (27.04%) had phlegm and blood stasis syndrome, 38 cases (19.39%) had yang-qi deficiency syndrome, and 30 cases (15.31%) had heat retention and fluid consumption syndrome. Conclusion: Treatment with TCM derived therapies may increase the survival time of patients with stage IV esophageal SCC. Since these patients were diagnosed with different TCM syndromes, individualized TCM therapy is essential for improving symptoms and survival.Keywords
This publication has 25 references indexed in Scilit:
- Efficacy of traditional Chinese medicine in treating cancerBiomedical Reports, 2015
- Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalitiesWorld Journal of Gastrointestinal Oncology, 2014
- Epidemiology of Esophageal Cancer in Japan and ChinaJournal of Epidemiology, 2013
- TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysisNucleic Acids Research, 2012
- Syndrome differentiation in modern research of traditional Chinese medicineJournal of Ethnopharmacology, 2012
- Traditional Chinese Medicinal Herbs in the Treatment of Patients with Esophageal Cancer: A Systematic ReviewGastroenterology Clinics of North America, 2009
- Environmental Causes of Esophageal CancerGastroenterology Clinics of North America, 2009
- Esophageal cancer: epidemiology, pathogenesis and preventionNature Clinical Practice Gastroenterology & Hepatology, 2008
- Molecular Basis for Cold-Intolerant Yang-Deficient Constitution of Traditional Chinese MedicineThe American Journal of Chinese Medicine, 2008
- Esophageal CancerThe New England Journal of Medicine, 2003